Northwire Canada EditionThursday, October 15, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Other Routine +

Illumisoft Lighting Corp. Provides Corporate Update Following Commencement of Trading

Illumisoft Lights Path to Commercialization Amidst Regulatory Tailwinds and Debt Maturity Risks

By The Northwire Desk — AI Analysis May 05, 2026 · 09:17 UVC · 0.465 Illumisoft Lighting Corp.
Executive Summary

Corporate Update Post-Listing

  • Illumisoft Lighting Corp. (TSXV: UVC) provided a comprehensive update following its TSX Venture Exchange listing commencement on April 23, 2026.
  • The company highlighted clinical efficacy data for SaniLume upper room UV disinfection devices from the University of Leeds testing.
  • Regulatory tailwinds were emphasized, citing new Canadian healthcare standards (CSA Z8000:24 and CSA Z317.12:25) mandating automated disinfection technologies in architectural design.
  • Development of SaniLux, a patented Far UVC technology for occupied spaces, was announced alongside commercialization plans.
Material Impact

Positive Drivers

  • Regulatory Mandates: The identification of upper room GUV systems as essential in CSA Z8000:24 creates a potential long-term revenue floor for the SaniLume product line, reducing reliance on voluntary adoption.
  • Clinical Validation: Independent testing showing >99% inactivation of key pathogens (Pseudomonas aeruginosa, Staphylococcus aureus) provides tangible proof of concept for investors and customers.
  • Strategic Alignment: The involvement of Resilience Reserve adds credibility to the management team's vision, particularly given Anderson's background in media/tech innovation.
UVC · Price
Company Overview

Corporate Structure

  • Former Name: Gstaad Capital Corp.
  • Current Name: Illumisoft Lighting Corp. (TSXV: UVC).
  • Transaction Type: Qualifying Transaction (QT) with Claranova Technologies Inc., completed April 21, 2026.
  • Listing Date: April 23, 2026 on TSX Venture Exchange.
Read the original news release →

More from Illumisoft Lighting Corp.

Jun 30, 2026 · 07:01

Illumisoft and Capgemini Collaborate to Advance Human-Safe Far UVC Platform for Airborne Pathogen Risk Reduction in High-Occupancy Indoor Environments

M&A / Property Apr 21, 2026 · 21:14

Shell company completes reverse takeover with germicidal UV product

M&A / Property